DPH Share Price

Open 1429.00 Change Price %
High 1444.00 1 Day 19.00 1.34
Low 1425.90 1 Week 66.00 4.80
Close 1441.00 1 Month 114.00 8.59
Volume 102417 1 Year 441.50 44.17
52 Week High 1462.00
52 Week Low 811.00
DPH Important Levels
Resistance 2 1457.78
Resistance 1 1450.86
Pivot 1436.97
Support 1 1431.14
Support 2 1424.22
LON UK Most Active Stocks
FITB 0.78 358.82%
FITB 0.78 358.82%
CWC 74.60 0.27%
CWC 74.60 0.27%
CWC 74.60 0.27%
INC 0.04 -20.00%
LGO 0.13 -7.14%
LGO 0.13 -7.14%
LGO 0.13 -7.14%
LLOY 64.98 -0.72%
More..
LON UK Top Gainers Stocks
AKT 28.50 5177.78%
HHR 58.00 900.00%
MLD 10.00 700.00%
FITB 0.78 358.82%
FITB 0.78 358.82%
MES 0.28 75.00%
MES 0.28 75.00%
MES 0.28 75.00%
PFLM 5.75 64.29%
BAC 22.50 60.71%
More..
LON UK Top Losers Stocks
ENDV 0.02 -99.85%
KEA 0.10 -91.30%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
DCP 0.50 -75.61%
PCI 3.50 -53.27%
PCI 3.50 -53.27%
CSFG 0.62 -40.95%
BHR 0.02 -33.33%
More..

Dechra Pharmaceuticals PLC (LON: DPH)

DPH Technical Analysis 5
As on 18th Jan 2017 DPH Share Price closed @ 1441.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1249.24 & Strong Buy for SHORT-TERM with Stoploss of 1310.91 we also expect STOCK to react on Following IMPORTANT LEVELS.
DPH Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
DPH Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.dechra.com
DPH Address
DPH
24 Cheshire Avenue
Cheshire Business Park
Northwich, CW9 7UA
United Kingdom
Phone: 44 1606 814 730
Fax: 44 1606 814 731
DPH Latest News
Dechra Pharmaceuticals plc 7.8% Potential Upside Indicated by Cantor Fitzgerald   DirectorsTalk Interviews   - 17th Jan 17
Dechra® Pharmaceuticals PLC Trading Update   PR Newswire (press release)   - 17th Jan 17
Market Scope: F-Score and Volatility Review for Dechra Pharmaceuticals plc ...   The Business Journal   - 17th Jan 17
Brokerages Set Dechra Pharmaceuticals plc (DPH) Price Target at $1337.43   Sports Perspectives   - 28th Dec 16
Dechra Pharmaceuticals plc (DPH) PT Raised to GBX 1320   The Cerbat Gem   - 19th Dec 16
Is Dechra Pharmaceuticals plc a better buy than GlaxoSmithKline plc after ...   Motley Fool UK   - 05th Sep 16
Dechra® Pharmaceuticals PLC: Trading Update & Notice of 2016 Annual Results   PR Newswire (press release)   - 12th Jul 16
Dechra Pharmaceuticals PLC, Agrees Acquisition of US-based Putney, Inc for ...   PR Newswire (press release)   - 15th Mar 16
Dechra Pharmaceuticals PLC: Half-Yearly Financial Report 2016   PR Newswire (press release)   - 22nd Feb 16
Dechra® Pharmaceuticals PLC (Dechra or the Group) : Trading Update   PR Newswire (press release)   - 14th Jan 16
Interactive Technical Analysis Chart Dechra Pharmaceuticals PLC ( DPH LON UK )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Dechra Pharmaceuticals PLC
DPH Business Profile
Dechra Pharmaceuticals PLC is engaged in the development, manufacture, distribution, sale, and marketing of veterinary pharmaceuticals worldwide. It markets and sells licensed branded pharmaceuticals and specialist pet foods to the veterinary professionals in Europe, as well as manufactures products for third party customers. The company also markets and sells a range of endocrine, ophthalmic, dermatological, and equine products in North America. In addition, it develops and licenses its branded veterinary product portfolio of novel and generic pharmaceuticals, and specialist pet diets. The company distributes its products through a mixture of its own direct sales, wholesalers, and national distributor channels. Dechra Pharmaceuticals PLC is headquartered in Northwich, the United Kingdom.